0001127602-20-032415.txt : 20201228 0001127602-20-032415.hdr.sgml : 20201228 20201228194632 ACCESSION NUMBER: 0001127602-20-032415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201224 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACKAY GEOFFREY CENTRAL INDEX KEY: 0001741849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38537 FILM NUMBER: 201419764 MAIL ADDRESS: STREET 1: C/O AVROBIO, INC. STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc. CENTRAL INDEX KEY: 0001681087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810710585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7819626030 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AvroBio, Inc. DATE OF NAME CHANGE: 20160729 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-12-24 0001681087 AVROBIO, Inc. AVRO 0001741849 MACKAY GEOFFREY C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 1 1 President & CEO Common Stock 2020-12-24 4 M 0 100000 .4132 A 245123 D Common Stock 72604 I By daughter of reporting person Common Stock 72604 I By son of reporting person Common Stock 200000 I By The Geoff R. MacKay Irrevocable Trust Stock Option (Right to Buy) .4132 2020-12-24 4 M 0 100000 0 D 2026-04-12 Common Stock 100000 142013 D This filing relates to the exercise of a Stock Option. No shares of Common Stock were sold by the Reporting Person, and the shares of Common Stock received upon exercise of the Stock Option are subject to a lock-up agreement with Morgan Stanley & Co. LLC and Cowen and Company, LLC. 25% of the shares vested on July 1, 2017, and the remaining 75% vest in equal quarterly installments thereafter over a three-year period. /s/ Steven N. Avruch, Attorney-in-Fact for Geoffrey MacKay 2020-12-28